Cargando…

Staphylococcus aureus Lipase 1 Enhances Influenza A Virus Replication

Influenza A virus (IAV) causes annual epidemics of respiratory disease in humans, often complicated by secondary coinfection with bacterial pathogens such as Staphylococcus aureus. Here, we report that the S. aureus secreted protein lipase 1 enhances IAV replication in vitro in primary cells, includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Goncheva, Mariya I., Conceicao, Carina, Tuffs, Stephen W., Lee, Hui-Min, Quigg-Nicol, Marlynne, Bennet, Ian, Sargison, Fiona, Pickering, Amy C., Hussain, Saira, Gill, Andrew C., Dutia, Bernadette M., Digard, Paul, Fitzgerald, J. Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343990/
https://www.ncbi.nlm.nih.gov/pubmed/32636247
http://dx.doi.org/10.1128/mBio.00975-20
Descripción
Sumario:Influenza A virus (IAV) causes annual epidemics of respiratory disease in humans, often complicated by secondary coinfection with bacterial pathogens such as Staphylococcus aureus. Here, we report that the S. aureus secreted protein lipase 1 enhances IAV replication in vitro in primary cells, including human lung fibroblasts. The proviral activity of lipase 1 is dependent on its enzymatic function, acts late in the viral life cycle, and results in increased infectivity through positive modulation of virus budding. Furthermore, the proviral effect of lipase 1 on IAV is exhibited during in vivo infection of embryonated hen’s eggs and, importantly, increases the yield of a vaccine strain of IAV by approximately 5-fold. Thus, we have identified the first S. aureus protein to enhance IAV replication, suggesting a potential role in coinfection. Importantly, this activity may be harnessed to address global shortages of influenza vaccines.